Be the first to like.

Share

Silicon Valley has audacious plans for shaking up the way we diagnose — and cure — disease.

But the life sciences are far more challenging than the tech titans of this world might realize: There are countless regulatory hurdles, health care delivery obstacles, and — most of all — the challenge of untangling the extraordinarily complex biology of the human body.

Still, giants like Apple, Google, IBM, Intel, and Microsoft are charging ahead. Here, a look at three diseases they’re attacking with a vengeance … and how they might stumble:

Be the first to like.

Share
STAT

Leave a Reply